Roadrunner Research

San Antonio, Texas 78258

1 studies enrolling now · 29 studies all time

What they study most

Acute Migraine With or Without Aura, Adult Attention Deficit Hyperactivity Disorder, Attention Deficit Hyperactivity Disorder, Attention Deficit Hyperactivity Disorder (ADHD), Attention-Deficit/Hyperactivity Disorder, Autism Spectrum Disorder, Autism Spectrum Disorders, Cerebral Palsy, Cognitive Dysfunction, Down Syndrome, Epilepsy, Fragile X Syndrome

Studies at this site

• A Study of Pitolisant in Patients With Prader-Willi Syndrome — Recruiting now
• Open-label Study to Evaluate Long-term Safety and Efficacy of SPN-812 (Viloxazine Extended-release Capsule) — Running, not enrolling
• A Phase 2 Study to Evaluate the Safety and Efficacy of Pitolisant in Patients With Prader-Willi Syndrome, Followed by an Open Label Extension — Completed
• A Study to Evaluate Safety, and Efficacy of SUVN-G3031 (Samelisant) in Patients With Narcolepsy With and Without Cataplexy — Completed
• Treatment of Impulsive Aggression in Subjects With ADHD in Conjunction With Standard ADHD Treatment (CHIME 1) — Completed
• Study to Assess the Safety and Efficacy of ONZETRA® Xsail® for the Acute Treatment of Episodic Migraine With or Without Aura in Adolescents — Stopped early
• An Efficacy and Safety Evaluation of HORIZANT in Adolescents With Moderate-to-Severe Primary RLS — Status unconfirmed
• Safety and Efficacy Study in Preschool Children Aged 4-5 Years With Attention-deficit/Hyperactivity Disorder (ADHD) — Completed
• Efficacy and Safety of Eslicarbazepine Acetate (BIA 2-093) as Adjunctive Therapy for Refractory Partial Seizures — Completed
• Evaluating The Efficacy And Safety Of Donepezil Hydrochloride (HCl) (Aricept) In Treating Cognitive Dysfunction Exhibited By Children With Down Syndrome — Completed
• Dasotraline Pediatric ADHD Study — Completed
• Safety and Tolerability Study of SPD489 in Preschool Children Aged 4-5 Years, Diagnosed With Attention-deficit/Hyperactivity Disorder — Completed
• A Study to Investigate the Efficacy and Safety of Balovaptan (RO5285119) in Participants With Autism Spectrum Disorder (ASD) — Stopped early
• Evaluating The Efficacy And Safety Of Donepezil Hydrochloride (Aricept) In The Treatment Of The Cognitive Dysfunction Exhibited By Children With Down Syndrome, Aged 6 To 10 — Stopped early
• An Extension Study to Evaluate the Long-Term Safety and Tolerability of Ubrogepant in the Treatment of Migraine — Completed
• BOTOX® Open-Label Treatment in Pediatric Upper Limb Spasticity — Completed
• BOTOX® Open-Label Treatment in Pediatric Lower Limb Spasticity — Completed
• BOTOX® Treatment in Pediatric Lower Limb Spasticity — Completed
• BOTOX® Treatment in Pediatric Upper Limb Spasticity — Completed
• Eslicarbazepine Acetate Monotherapy Long Term Study — Completed
• Evaluating The Efficacy And Safety Of Donepezil Hydrochloride (Aricept) In The Treatment Of The Cognitive Dysfunction Exhibited By Children With Down Syndrome, Aged 11 To 17 — Stopped early
• Long Term Safety Study of Study Drug (Eszopiclone) in Children and Adolescents With ADHD -Associated Insomnia — Completed
• Dasotraline Adult ADHD Study — Completed
• A Study of RG7314 to Investigate Efficacy and Safety in Individuals With Autism Spectrum Disorders (ASD) — Completed
• Dasotraline SEP360-105 Pediatric PK/PD Study — Completed
• Open Label Extension Study of STX209 (Arbaclofen) in Autism Spectrum Disorders — Stopped early
• Efficacy and Safety Study of STX209 (Arbaclofen) for Social Withdrawal in Adolescents and Adults With Fragile X Syndrome — Completed
• Study of Arbaclofen for the Treatment of Social Withdrawal in Subjects With Autism Spectrum Disorders — Completed
• Efficacy and Safety Study of STX209 (Arbaclofen) for the Treatment of Social Withdrawal in Children With Fragile X Syndrome — Completed